I have obtained more knowledge on the full process of a clinical trial, from the pre-study and initiation until close-out. Furthermore, I have learned what are crucial points to review during and in between monitoring visits and what are the responsibilities of the parties involved - Interactive course, small group, motivating trainer.

A really good one-day course which gives you all you need to know, really to the point and useable right away. - Great teacher! The course was very interactive and I was a bit scared to be bored but I was not.

Having different types of stakeholders around the table was an enriching experience - I received an overview of the relevant parts constituting a clinical research agreement. It helped to build confidence in the CTA we will be working on.

Everything was very good: loved the course materials which gave room to write next to the slides and the pen which was also a marker. Furthermore, the interactivity of the course was great to stay focused.

Interactive, room for questions/debate which ensures to keep our attention all day for this very theoretical content of the course.

It has been a very interesting course and I found the real case scenarios very useful. I registered for the touchpoint with the trainer and appreciated the oppportunity to ask my questions and received clarification on specific points.

"The ECCRT Open House was a very interesting conference day about Learning and Development in Clinical Research. It was not only informative, but open and dynamic. I gathered several tools and tips, which I could implement immediately within my team. Moreover, it was very stimulating to share ideas and experiences with other attendees and see what

Workshop to apply skills learned was very good, Interaction with regulatory and industry participants.

Trainers have experience in the field and participants have already good background to share concerns, discuss, ask the relevant questions.   

Nice interaction with the trainers. They were really experts in the topic they were discussing. I would recommend this training to people who have a minimal or no experience in drug development to attend as it was a very nice high level overview and gave a good impression of what aspects are needed.